Rodrigo Entrialgo‐Cadierno

Author

Centro de Investigación Biomédica en Red de Cáncer ORCID

Also Known As

Rodrigo Entrialgo-Cadierno, Rodrigo Entrialgo‐Cadierno, Rodrigo Entrialgo‑Cadierno

Publications

537

Citations

H-Index

Concepts

All Affiliations

Centro de Investigación Biomédica en Red de Cáncer Navarre Institute of Health Research Universidad de Navarra Clinica Universidad de Navarra Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas

About

Rodrigo Entrialgo‐Cadierno is an author at Centro de Investigación Biomédica en Red de Cáncer specializing in medicine, cancer research, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	153
2	Engineering	1	1	103
3	Biochemistry	1	1	103
4	Cell Biology	1	1	50
5	Microbiology	1	1	103

Rodrigo Entrialgo‐Cadierno

Publications

280

Citations

H-Index

Page 1

	Year	Citations
De novo biosynthesis of myricetin, kaempferol and quercetin in Streptomyces albus and Streptomyces coelicolor Laura Marín, Ignacio Gutiérrez‐del‐Río, Rodrigo Entrialgo‐Cadierno, PLoS ONE Industrial ActinomycetesEngineeringDe Novo BiosynthesisSecondary MetabolitePolyphenolics	2018	103
The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas Karmele Valencia, Oihane Erice, Kaja Kostyrko, Journal of Clinical Investigation Cancer ResearchResident MirnasTumor MicroenvironmentCancer GenomicsKras-driven Oncogenesis	2019	50
FOSL1 promotes cholangiocarcinoma via transcriptional effectors that could be therapeutically targeted Adrián Vallejo, Oihane Erice, Rodrigo Entrialgo‐Cadierno, Journal of Hepatology	2021	44
LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth Oihane Erice, Shruthi Narayanan, Iker Feliu, Clinical Cancer Research	2023	30
The phospholipid transporter PITPNC1 links KRAS to MYC to prevent autophagy in lung and pancreatic cancer Rodrigo Entrialgo‐Cadierno, Cristina Cueto‐Ureña, Connor Welch, Molecular Cancer	2023	21
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer Irati Macaya, Marta Román, Connor Welch, Nature Communications	2023	20
The C5a/C5aR1 Axis Promotes Migration of Tolerogenic Dendritic Cells to Lymph Nodes, Impairing the Anticancer Immune Response Yaiza Senent, Ana Remírez, David Repáraz, Cancer Immunology Research	2024	12

Page 1